Back to 
&PARTNERS
&PARTNERS
BTAIQ2 quarters
Position history for &PARTNERS's holdings in BioXcel Therapeutics, Inc.
Yes. &Partners holds 83,588 shares of BTAIQ (BioXcel Therapeutics), worth $117,859, as of its Q2 2026 13F filing. It increased the position by 2,724 shares (+3.4%) from Q1 2026. &Partners has held BTAIQ since Q1 2026, across 2 quarterly 13F filings.
Current Value
$117,859
Current Shares
83,588
Total Value Change
+$9,501
Total Shares Change
+2,724
Quarter-by-Quarter History
Other major holders of BTAIQ: MILLENNIUM MANAGEMENT LLC, OAKTREE CAPITAL MANAGEMENT LP